UK-RNQD-220099. DOP: June 2022.
Watch the Clear Horizons TV AD Episode:
Latest updates in care in Atopic Dermatitis
Dr Laura Savage
Consultant Dermatologist at Leeds Teaching Hospitals NHS Trust, with a special interest in Medical Dermatology and Honorary Senior Lecturer, Faculty of Medicine and Health, University of Leeds
Dr Andrew Pink
Consultant Dermatologist and Director of the adult Clinical Trials Unit at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals, London
Dr Sandy McBride
Consultant Dermatologist, Royal Free London NHS Foundation Trust
Professor Richard Warren
Consultant Dermatologist in Manchester, Academic Vice President of the British Association of Dermatologists and Lead for Early Phase trial research across the Northern Care Alliance in Greater Manchester
Dr Amy Foulkes
Consultant Dermatologist at Salford Royal NHS Foundation Trust and an Honorary Senior Clinical Lecturer at the University of Manchester
1. RINVOQ Summary of Product Characteristics
UK-RNQD-210310. Date of preparation: March 2022
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
Adverse events should also be reported to AbbVie on GBPV@abbvie.com
